Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain

Decera Clinical Education Oncology Podcast · Jan 8, 2021 · 23m

In this episode, Félix Guerrero Ramos, MD, PhD, FEBU, and Óscar Rodríguez-Faba, MD, discuss in Spanish the latest immuno-oncology developments in the treatment of urothelial cancer.

Presenters:

Félix Guerrero Ramos, MD, PhD, FEBU

Teaching Collaborator

Department of Surgery

Medicine School

Universidad Complutense de Madrid

Attending Urologist

Department of Urology

UroOncology Unit

Madrid, Spain

Óscar Rodríguez-Faba, MD

Urologist

Uro-Oncology

Fundació Puigvert

Barcelona, Catalonia, Spain

Content based on an online IME program supported by educational grants from EMD Serono, Inc and Pfizer.

Link…